Strategies and delivery systems for cell-based therapy in autoimmunity
This review article explores the potential of engineering antigen-presenting cells (APCs) for the immunotherapy of autoimmune diseases. It discusses various strategies for modifying APCs to induce antigen-specific tolerance, thereby mitigating autoimmune responses. The review covers recent advanceme...
Saved in:
Published in | Frontiers in Drug Delivery Vol. 4 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
08.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This review article explores the potential of engineering antigen-presenting cells (APCs) for the immunotherapy of autoimmune diseases. It discusses various strategies for modifying APCs to induce antigen-specific tolerance, thereby mitigating autoimmune responses. The review covers recent advancements in APC engineering techniques, including genetic modification and nanoparticle-based approaches, and evaluates their efficacy in preclinical models and clinical trials. Additionally, challenges and future directions for the development of APC-based immunotherapies for autoimmunity – and other forms of cell-based immunotherapy – are discussed. Along this direction, this review (
i
) describes various strategies for engineering APCs, including genetic modification, nanoparticle delivery systems, and
ex vivo
manipulation techniques; (
ii
) discusses the selection of target antigens and the design of APC-based immunotherapies, and (
iii
) reviews preclinical models used to evaluate the efficacy and safety of engineered APCs in inducing antigen-specific tolerance. |
---|---|
Bibliography: | Reviewed by: Taskeen Janjua, The University of Queensland, Australia Edited by: Cristian Vilos, University of Talca, Chile Rohit K Sharma, University of California, Berkeley, United States |
ISSN: | 2674-0850 2674-0850 |
DOI: | 10.3389/fddev.2024.1436842 |